BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32217002)

  • 1. Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer.
    Dholakia J; Llamocca E; Quick A; Salani R; Felix AS
    Gynecol Oncol; 2020 Jun; 157(3):716-722. PubMed ID: 32217002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
    Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
    Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.
    Felix AS; McLaughlin EM; Caan BJ; Cohn DE; Anderson GL; Paskett ED
    Int J Cancer; 2020 Jul; 147(2):404-412. PubMed ID: 31618444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.
    Felix AS; Brasky TM; Cohn DE; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel C; Boggess JF; Pearl ML; Ioffe OB; Deng W; Miller DS; Brinton LA
    Int J Cancer; 2018 Mar; 142(6):1102-1115. PubMed ID: 29063589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Patient Experience With Care, Race and Ethnicity, and Receipt of CRC Treatment Among SEER-CAHPS Patients With Multiple Comorbidities.
    Navarro S; Tsui J; Barzi A; Stern MC; Pickering T; Farias AJ
    J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237074. PubMed ID: 38150827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
    Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
    Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of race, comorbid conditions and obesity on survival endpoints in women with high grade endometrial carcinoma.
    Fucinari J; Elshaikh MA; Ruterbusch JJ; Khalil R; Dyson G; Shultz D; Ali-Fehmi R; Cote ML
    Gynecol Oncol; 2021 Jul; 162(1):134-141. PubMed ID: 33985795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in survival among women with endometrial cancer in an equal access system.
    Park AB; Darcy KM; Tian C; Casablanca Y; Schinkel JK; Enewold L; McGlynn KA; Shriver CD; Zhu K
    Gynecol Oncol; 2021 Oct; 163(1):125-129. PubMed ID: 34325938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
    Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
    Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
    Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
    Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
    Cosgrove CM; Cohn DE; Rhoades J; Felix AS
    Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Disparities in Survival Outcomes of Patients With Serous Epithelial Ovarian Cancer: A Retrospective Cohort Analysis.
    Shingala K; Stavros S; Parag S; Tercek A; Makhani SS; Bouz A; Galbo A; Chung-Bridges K
    Cureus; 2023 Jan; 15(1):e34389. PubMed ID: 36874646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic differences in type II endometrial cancer mortality outcomes: The contribution of sociodemographic, clinicopathologic, and treatment factors.
    Karia PS; Huang Y; Tehranifar P; Wright JD; Genkinger JM
    Gynecol Oncol; 2023 Jan; 168():119-126. PubMed ID: 36434946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas.
    Rodriguez VE; LeBrón AMW; Chang J; Bristow RE
    Cancer; 2021 Jul; 127(14):2423-2431. PubMed ID: 33721357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
    Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
    Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in Breast Cancer Death With Adjuvant Chemotherapy Among US Women According to Race, Ethnicity, and the 21-Gene Recurrence Score.
    Huang HC; Calip GS; Weiss J; Simons Y; Gadi VK; Danciu OC; Rauscher GH; Hoskins KF
    J Natl Compr Canc Netw; 2024 Jan; 22(1D):e237077. PubMed ID: 38190799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receipt of Guideline-Concordant Care Does Not Explain Breast Cancer Mortality Disparities by Race in Metropolitan Atlanta.
    Collin LJ; Yan M; Jiang R; Gogineni K; Subhedar P; Ward KC; Switchenko JM; Lipscomb J; Miller-Kleinhenz J; Torres MA; Lin J; McCullough LE
    J Natl Compr Canc Netw; 2021 Aug; 19(11):1242-1251. PubMed ID: 34399407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival differences by race/ethnicity among children and adolescents diagnosed with germ cell tumors.
    Williams LA; Frazier AL; Poynter JN
    Int J Cancer; 2020 May; 146(9):2433-2441. PubMed ID: 31304572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes.
    Winkler SS; Tian C; Casablanca Y; Bateman NW; Jokajtys S; Kucera CW; Tarney CM; Chan JK; Richardson MT; Kapp DS; Liao CI; Hamilton CA; Leath CA; Reddy M; Cote ML; O'Connor TD; Jones NL; Rocconi RP; Powell MA; Farley J; Shriver CD; Conrads TP; Phippen NT; Maxwell GL; Darcy KM
    Gynecol Oncol; 2024 Jan; 184():31-42. PubMed ID: 38277919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial cancer risk and trends among distinct African descent populations.
    Medina HN; Penedo FJ; Joachim C; Deloumeaux J; Koru-Sengul T; Macni J; Bhakkan B; Peruvien J; Schlumbrecht MP; Pinheiro PS
    Cancer; 2023 Sep; 129(17):2717-2726. PubMed ID: 37357566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.